IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q4 2015 Holdings

Filed 2016-02-16 | 18 holdings | $6.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cellectis(CLLS)SPONDS ADR15117K103$3.1M100,00049.4%
Adaptimmune(ADAPY)SPONDS ADR00653A107$3.0M250,00048.0%
Chiasma(CHMA)Common16706W102$40.7K2,080,5950.6%
ProteonCommon74371L109$31.3K2,017,8720.5%
ParatekCommon699374302$24.7K1,301,4130.4%
SientraCommon82621J105$13.0K2,199,0120.2%
CempraCommon15130J109$11.9K383,9350.2%
Dicerna(DRNAUSD)Common253031108$11.2K945,7570.2%
TobiraCommon88883P101$5.9K589,2440.1%
Lombard MedicalCommonG55598109$4.4K3,473,4520.1%
InnocollSPONDS ADR45780Q103$4.2K555,5550.1%
RegulusCommon75915K101$2.9K327,3500.0%
Cymabay(CBAYUSD)Common23257D103$2.7K1,600,0000.0%
Dermira(DERMEUR)Common24983L104$2.4K70,0000.0%
AntheraCommon03674U201$2.0K437,9940.0%
ChemoCentryx(CCXIEUR)Common16383L106$1.7K215,0000.0%
Oncogenex PharmaCommon68230A106$475396,1040.0%
Epirus BiopharmaCommon29428P107$247,8960.0%